Recording High Frequency Oscillations in Patients With Tumors and Epilepsy (HFO)

November 30, 2023 updated by: University of Zurich

Recording High Frequency Oscillations in Patients With Tumors and Epilepsy.

The investigators want to characterize high-frequency oscillations (HFOs) in intracranial recordings, which may occur as markers of epileptogenic tissue and also under physiological stimulation.

The investigators want to show that recording of high-frequency oscillations (HFOs) is feasible in our project population both intraoperatively and during presurgical physiological conditions.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

120

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

  1. Patients with epilepsy where a surgical resection is considered.
  2. Patients where a tumor will be resected that has caused preoperative seizures.
  3. Patients where a tumor will be resected that has not caused preoperative seizures.

Description

Inclusion Criteria:

  • Patients intend to be treated at the Klinik für Neurochirurgie
  • Patients fall into one of the patient groups: (1) Patients with symptomatic epilepsy with focal and/or secondary generalized seizures resistant to medication where a neurosurgical resection is considered as an intervention of epilepsy surgery. (2)Patients where a tumor is planned to be resected that has caused preoperative seizures. (3) Patients where a tumor is planned to be resected that has not caused preoperative seizures.
  • Male and Female subjects 18 years to 99 years of age
  • Written informed consent after participants' information

Exclusion Criteria:

  • contraindications on ethical grounds
  • known or suspected non-compliance, drug or alcohol abuse,
  • enrolment into a clinical trial within last 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
epilepsy
epilepsy patients
patients perform simple tasks like watching a video or memorizing items
tumor with epilepsy
tumor patients with epileptic seizures
patients perform simple tasks like watching a video or memorizing items
tumor without epilepsy
tumor patients without epileptic seizures
patients perform simple tasks like watching a video or memorizing items

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
HFO (high-frequency oscillations) occurrence
Time Frame: 1 week
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Johannes Sarnthein, Prof Dr, Universitatsspital Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

December 15, 2014

First Submitted That Met QC Criteria

December 18, 2014

First Posted (Estimated)

December 19, 2014

Study Record Updates

Last Update Posted (Actual)

December 1, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HFO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on cognitive testing

Subscribe